Purpose of Review To provide an evidence-based approach to the use of therapies that are
prescribed to improve the natural history of HTLV-1–associated myelopathy/tropical spastic …

Human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare inflammatory disease causing unremitting and progressive …

Corticosteroids are most commonly used to treat HTLV-1-associated myelopathy (HAM);
however, their clinical efficacy has not been tested in randomized clinical trials. This …

Human T-cell leukemia virus type 1 (HTLV-1) is a replication-competent human retrovirus
associated with two distinct types of diseases: a malignancy of mature CD4+ T cells called …

Background: HTLV-1 is a neglected sexually transmitted infection despite being the cause of
disabling neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis …

Human T-lymphotropic virus type 1 (HTLV-1) is the etiologic agent of both adult T-cell
leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis …

Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately
10–20 million people worldwide. While the majority of infected people are asymptomatic …

Human T cell leukemia virus type 1 (HTLV-1) is a human retrovirus that is associated with
two main diseases: HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) …

Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is an inflammatory neurodegenerative disease that affects motor …

Background As human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is a rare chronic neurological disease, large scale studies to …